Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Vago

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Nature Communications|March 27, 2019
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCTMaddalena Noviello, Francesco Manfredi, Eliana Ruggiero, et al.
Bone Marrow Transplantation|August 8, 2025
Advancing the Integration of 'Basic/Fundamental' and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to ProgressDonal P McLornan, Mette D Hazenberg, Fabio Ciceri, et al.
Blood|April 14, 2026
T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradicationFrancesca Marzuttini, Alessia Potenza, Ludovica Celli, et al.
Nature Medicine|January 9, 2023
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 studyAngela Genchi, Elena Brambilla, Francesca Sangalli, et al.
British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Blood|July 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibodyChristian Augsberger, Gerulf Hänel, Wei Xu, et al.
Transplantation and Cellular Therapy|May 9, 2021
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei TrapiantiAlessandra Picardi, Nicoletta Sacchi, Valeria Miotti, et al.
Haematologica|May 13, 2022
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantationAnnalisa Ruggeri, Liesbeth C De Wreede, Carlheinz R Müller, et al.
Nature Communications|April 30, 2024
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCIDDaniela Cesana, Maria Pia Cicalese, Andrea Calabria, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Nature Communications|March 27, 2019
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCTMaddalena Noviello, Francesco Manfredi, Eliana Ruggiero, et al.
Bone Marrow Transplantation|August 8, 2025
Advancing the Integration of 'Basic/Fundamental' and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to ProgressDonal P McLornan, Mette D Hazenberg, Fabio Ciceri, et al.
Blood|April 14, 2026
T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradicationFrancesca Marzuttini, Alessia Potenza, Ludovica Celli, et al.
Nature Medicine|January 9, 2023
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 studyAngela Genchi, Elena Brambilla, Francesca Sangalli, et al.
British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Blood|July 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibodyChristian Augsberger, Gerulf Hänel, Wei Xu, et al.
Transplantation and Cellular Therapy|May 9, 2021
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei TrapiantiAlessandra Picardi, Nicoletta Sacchi, Valeria Miotti, et al.
Haematologica|May 13, 2022
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantationAnnalisa Ruggeri, Liesbeth C De Wreede, Carlheinz R Müller, et al.
Nature Communications|April 30, 2024
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCIDDaniela Cesana, Maria Pia Cicalese, Andrea Calabria, et al.
Pageof 12